Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,065.00
-40.00 (-0.97%)
At close: Sep 1, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 44.99 billion as of September 2, 2026. Its market cap has decreased by -33.81% in one year.
Market Cap
44.99B
Enterprise Value
35.87B
Revenue
19.60B
Ranking
n/a
PE Ratio
14.93
Stock Price
4,065.00
ChartMarket Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 44.99B, a decrease of -51.46%. That is a compound annual growth rate of -34.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 44.99B | -38.85% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Semi Total Solution | 81.52B |
| NBR Motion | 57.74B |
| ALT Co., Ltd. | 55.78B |
| ERCOHS Agricultural Corporation Co.,Ltd | 55.15B |
| Laseroptek | 48.02B |
| GITSN | 36.35B |
| New Kids On | 30.93B |
| JNB Co., Ltd. | 30.87B |